KIAA2018, also known as Upstream Transcription Factor Family Member 3 (USF3), plays a significant role in the regulation of gene expression, impacting various cellular processes including cell growth, differentiation, and response to environmental stimuli. While specific details of KIAA2018's function are less defined compared to other well-studied proteins, its categorization as an upstream transcription factor suggests it may be involved in the initial stages of gene transcription regulation, possibly influencing the expression of genes critical for cellular homeostasis and development. The role of KIAA2018 in cellular physiology underscores the importance of understanding its regulatory mechanisms, as alterations in its activity could have profound effects on cellular function and contribute to the pathogenesis of various diseases.
The inhibition of KIAA2018 can occur through several molecular mechanisms, reflecting the complexity of transcriptional regulation within the cell. One mechanism involves the direct interaction with inhibitory proteins that can bind to KIAA2018, preventing it from binding to DNA and executing its role in transcriptional activation. Alternatively, post-translational modifications, such as phosphorylation, methylation, or ubiquitination, might alter KIAA2018's structure or localization, impeding its ability to interact with target genes or other components of the transcription machinery. Another layer of regulation could involve epigenetic modifications that change the accessibility of DNA regions targeted by KIAA2018, thereby indirectly inhibiting its function. Understanding these inhibitory pathways is crucial for unraveling KIAA2018's role in transcriptional regulation and its implications in disease, providing a foundation for the development of strategies aimed at modulating its activity in pathological conditions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May demethylate DNA, potentially modifying the transcription landscape and affecting KIAA2018 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Could alter histone acetylation, potentially affecting the expression of genes like KIAA2018. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
May affect histone acetylation and subsequently influence KIAA2018 gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Could inhibit mTOR signaling, indirectly affecting the expression of genes like KIAA2018. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
May inhibit PI3K signaling, potentially affecting KIAA2018 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Could affect the MAPK pathway, indirectly influencing KIAA2018 gene expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Might inhibit JNK, affecting pathways that could influence KIAA2018 expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Might inhibit PI3K, potentially affecting downstream targets such as KIAA2018. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Could affect immune and inflammation-related genes, potentially influencing KIAA2018 indirectly. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Might modulate various pathways, potentially having an indirect effect on KIAA2018 expression. | ||||||